Back to Agenda
Closing Session
Session Chair(s)
Sara Torgal, MPHARM
Global Regulatory Policy Lead, DIA, Switzerland
A must-attend review of the Conference Insights and Outcomes by the Conference Topic Leads, followed by closing remarks from the SVP and Managing Director of DIA EMEAI.
Speaker(s)
Ania Mitan
Senior Vice President & Managing Director, DIA EMEA and India, DIA, Switzerland
Álmath Spooner, PHD
Director of Regulatory Policy and Intelligence, AbbVie, Ireland
Take 5: Artificial Intelligence, Data Science & RWE
Marianne Lunzer, DrMed
Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care, AGES, Austria
Take 5: Clinical Trials Development & Operations
Matt Popkin, PHD
Senior Director, CMC Excellence, Global Regulatory Affairs, GSK, United Kingdom
Take 5: CMC & Product Quality
Sara Torgal, MPHARM
Global Regulatory Policy Lead, DIA, Switzerland
Take 5: International Collaboration & Regional Updates
Tim Chesworth
Senior Director Regulatory Affairs , Novartis, United Kingdom
Take 5: Medical Devices & Combination Products
James Whitehead, MBA, MSC
Former Senior Director Device & Digital Safety - AstraZeneca, Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Take 5: Pharmacovigilance & Safety
Claudia Ferreira
Scientific Programs Manager, DIA, Switzerland
Take 5: Professional Development
Rodrigo Palacios, MBA
Senior Director, Technical Regulatory Policy, F. Hoffmann-La Roche Ltd., Switzerland
Take 5: Regulatory Operations
Emma Du Four, MBA
Independent Regulatory and R&D Policy Professional, Independent, United Kingdom
Take 5: Regulatory Strategy & EU Pharmaceutical Policy
James Ryan, MSC
Director, Global HTA Policy , AstraZeneca (Global), UK, United Kingdom
Take 5: Value and Access
Have an account?